Peptide Mapping: A Quality by Design (QbD) Approach

Aplikace | 2017 | Agilent TechnologiesInstrumentace
HPLC
Zaměření
Farmaceutická analýza, Proteomika
Výrobce
Agilent Technologies
PDF verze ke stažení a čtení
 

Podobná PDF

Automated QbD-Based Method Development and Validation of Oxidative Degraded Atorvastatin
Quality‑by‑Design Approach to Stability Indicating Method Development for Linagliptin Drug Product
QbD Based Method Development on an Agilent 1290 Infinity UHPLC System Combined with a Seamless Method Transfer to HPLC Using Intelligent System Emulation Technology
Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC